TW224104B - - Google Patents

Info

Publication number
TW224104B
TW224104B TW081106143A TW81106143A TW224104B TW 224104 B TW224104 B TW 224104B TW 081106143 A TW081106143 A TW 081106143A TW 81106143 A TW81106143 A TW 81106143A TW 224104 B TW224104 B TW 224104B
Authority
TW
Taiwan
Prior art keywords
phosphoinositolglycan
inositol
mannose
galactose
adenosine
Prior art date
Application number
TW081106143A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of TW224104B publication Critical patent/TW224104B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
TW081106143A 1991-08-20 1992-08-04 TW224104B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4127495 1991-08-20

Publications (1)

Publication Number Publication Date
TW224104B true TW224104B (zh) 1994-05-21

Family

ID=6438668

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081106143A TW224104B (zh) 1991-08-20 1992-08-04

Country Status (22)

Country Link
US (1) US5624903A (zh)
EP (1) EP0532915B1 (zh)
JP (1) JP3361126B2 (zh)
KR (2) KR100264623B1 (zh)
AT (1) ATE147407T1 (zh)
AU (1) AU656396B2 (zh)
CA (1) CA2076424C (zh)
CZ (1) CZ290341B6 (zh)
DE (1) DE59207835D1 (zh)
DK (1) DK0532915T3 (zh)
ES (1) ES2096686T3 (zh)
FI (1) FI102842B (zh)
GR (1) GR3022895T3 (zh)
HR (1) HRP940834B1 (zh)
HU (1) HU210431B (zh)
IL (1) IL102859A (zh)
NO (1) NO303452B1 (zh)
SG (1) SG46639A1 (zh)
SK (1) SK281333B6 (zh)
TW (1) TW224104B (zh)
YU (1) YU66892A (zh)
ZA (1) ZA926232B (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE184611T1 (de) * 1991-11-29 1999-10-15 Hoechst Ag Peptide mit insulinartiger wirkung
ES2159283T3 (es) * 1992-02-29 2001-10-01 Aventis Res & Tech Gmbh & Co Complejos que contienen glicosil-fosfatidilinositol-proteinas y derivados de acido colanico, procedimiento para su preparacion y su utilizacion.
US5652221A (en) * 1994-11-07 1997-07-29 The University Of Virginia Patent Foundation Method of treating defective glucose metabolism using synthetic insulin substances
GB9618929D0 (en) 1996-09-11 1996-10-23 Univ London Metal containing carbohydrates from human tissue which regulate glycogen metabolism
GB9618934D0 (en) * 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in the treatment of diabetes and obesity
GB9618930D0 (en) 1996-09-11 1996-10-23 Univ London Metal containing carbohydrates from human tissue which regulate lipogenic activity
DE19649350A1 (de) * 1996-11-28 1998-06-04 Hoechst Ag Inositolglykane mit insulinartiger Wirkung
KR100481746B1 (ko) * 1996-11-28 2005-08-10 훽스트 악티엔게젤샤프트 인슐린-유사작용을갖는이노시톨글리칸및이를포함하는약제학적제제
EP2158923B1 (en) 1998-08-06 2013-02-27 Mountain View Pharmaceuticals, Inc. Peg-urate oxidase conjugates and use thereof
CH697081A5 (de) * 2002-01-22 2008-04-30 Andreas F Dr Schaub Zusammensetzung für die Unterstützung der Geburt eines menschlichen Föten.
EP1378517A1 (en) * 2002-07-05 2004-01-07 Aventis Pharma Deutschland GmbH Phosphoinositolglycan (PIG) binding protein from adipocytes
CA2491555C (en) * 2002-07-10 2012-09-11 Massachusetts Institute Of Technology Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycans
ITMI20030237A1 (it) * 2003-02-11 2004-08-12 Indena Spa Uso della conglutina di lupino per il trattamento del
DE102004054552A1 (de) * 2004-11-11 2006-05-18 Hcb Happy Child Birth Holding Ag Neue Zusammensetzung zur Erleichterung der Humangeburt
RU2435847C2 (ru) 2005-04-11 2011-12-10 Савиент Фармасьютикалз, Инк. Вариантная форма урат-оксидазы и ее использование
PL3321359T3 (pl) 2005-04-11 2021-06-28 Horizon Pharma Rheumatology Llc Wariantowe postacie oksydazy moczanowej i ich zastosowanie
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
KR101861547B1 (ko) 2009-06-25 2018-07-02 크레알타 파마슈티칼스 엘엘씨 페길화된 유리카아제 치료 중에 혈청 요산을 모니터링하여 주입 반응의 위험성 및 반응의 항체­매개 상실을 예측하는 방법 및 키트
CN102270762B (zh) * 2010-06-03 2014-08-20 清华大学 锂离子电池电极浆料及应用该电极浆料制备的电极片

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
US4906468A (en) * 1986-04-11 1990-03-06 The Rockefeller University Insulin activity messengers, their antibodies, and thereof
US4839466A (en) * 1986-04-11 1989-06-13 The Rockefeller University Insulin activity messengers

Also Published As

Publication number Publication date
ATE147407T1 (de) 1997-01-15
SG46639A1 (en) 1998-02-20
NO923252L (no) 1993-02-22
AU656396B2 (en) 1995-02-02
AU2110992A (en) 1993-02-25
DE59207835D1 (de) 1997-02-20
FI923702A (fi) 1993-02-21
EP0532915B1 (de) 1997-01-08
JP3361126B2 (ja) 2003-01-07
HRP940834B1 (en) 2000-08-31
CA2076424A1 (en) 1993-02-21
GR3022895T3 (en) 1997-06-30
NO303452B1 (no) 1998-07-13
JPH05301891A (ja) 1993-11-16
EP0532915A2 (de) 1993-03-24
FI923702A0 (fi) 1992-08-18
YU66892A (sh) 1995-10-24
IL102859A0 (en) 1993-01-31
HUT62013A (en) 1993-03-29
DK0532915T3 (da) 1997-07-07
ZA926232B (en) 1993-04-28
CZ255392A3 (en) 1993-03-17
CZ290341B6 (cs) 2002-07-17
KR100318706B1 (ko) 2001-12-28
ES2096686T3 (es) 1997-03-16
HRP940834A2 (en) 1997-04-30
EP0532915A3 (en) 1994-05-18
IL102859A (en) 1998-12-27
SK255392A3 (en) 1995-02-08
FI102842B1 (fi) 1999-02-26
NO923252D0 (no) 1992-08-19
FI102842B (fi) 1999-02-26
KR930004327A (ko) 1993-03-22
SK281333B6 (sk) 2001-02-12
CA2076424C (en) 2003-06-03
US5624903A (en) 1997-04-29
KR100264623B1 (ko) 2000-09-01
HU210431B (en) 1995-04-28

Similar Documents

Publication Publication Date Title
TW224104B (zh)
GEP20033002B (en) Osteoprotegerin Binding Protein and Receptors
EP0339237A3 (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
EP1440980A3 (en) Peptide analogs of human myelin basic protein
EP0378641A4 (en) Novel antimicrobial peptide, compositions containing same and uses thereof
AU1348188A (en) New cardiodilatin fragment, process for preparing same and use thereof
IL79433A0 (en) Aromatic compounds,their preparation and their use as pesticides
EP0339549A3 (en) Tyr-peptide analogs
AU1022999A (en) 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
AU611113B2 (en) Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds
AU1343388A (en) Iodinated polymers
EP0295679A3 (en) Physiologically-active novel peptides
IL105475A0 (en) Pharmaceutical compositions containing 1alpha,24(r)-dihydroxy-22(e)-dehydro-vitamin d3 for treating osteoporosis
AU634280B2 (en) Anticoagulant peptides
IL77848A (en) 3-acetylamino-4-methoxy-benzisothiazole s,s-dioxide,its preparation and pesticidal compositions containing it
HU896448D0 (en) Process for the preparation of anticoagulant peptides
EP0226842A3 (en) Substituted 1,4-naphthalenediones, processes for their preparation and pharmaceutical compositions containing them
IL89392A (en) Compositions for the treatment of osteoporosis in humans comprising 24, 25-dihydroxy-vitamin d3
MY103751A (en) Heterobicycloalkanes having pesticidal activity
WO1990003394A3 (fr) Nouvelles lymphokines, sequences d'adn codant pour ces lymphokines et compositions pharmaceutiques contenant ces lymphokines
DE3567874D1 (en) Esters from the family of the n-phosphonomethylglycine and their use for the preparation of known herbicides
IL103856A0 (en) Aminoalkyl-substituted 5,6-dihydro-dibenz(b,e)azepin-6,11-dione-11-oximes,their preparation and pharmaceutical compositions containing them
AU542310B2 (en) Glicentin related purified peptide having 30 amino acids
AU5110390A (en) Cdna coding for placental protein 9 (pp9), the isolation and use thereof
AU3277484A (en) Fungicidal composition of (0,0-dimethyl 0-(2,6-dichloro-4- methylphenyl) phosphorothisate)

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent